Elderly patients (60-75 years)

Clinical trials for Elderly patients (60-75 years) explained in plain language.

Never miss a new study

Get alerted when new Elderly patients (60-75 years) trials appear

Sign up with your email to follow new studies for Elderly patients (60-75 years), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Triple therapy aims to boost leukemia remission in seniors

Disease control Not yet recruiting

This Phase 3 trial will test whether adding homoharringtonine to the standard two-drug regimen of venetoclax and azacitidine improves remission rates in adults aged 60-75 with newly diagnosed acute myeloid leukemia (AML). About 308 participants will be randomly assigned to receiv…

Matched conditions: ELDERLY PATIENTS (60-75 YEARS)

Phase 3 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC

Elderly patients (60-75 years)

Get alerted when new Elderly patients (60-75 years) trials appear

Triple therapy aims to boost leukemia remission in seniors